BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B)— 510(k) K171404

Substantially Equivalent

Bausch + Lomb, Incorporated

FDA 510(k) clearance K171404 for BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B), Substantially Equivalent on 2017-07-17. Applicant: Bausch + Lomb, Incorporated. Device class: 2.

Clearance details

Applicant
Bausch + Lomb, Incorporated
Product code
Code HQD
Device class
Class 2
Regulation
21 CFR 886.5916
Advisory panel
Ophthalmic
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Rochester, NY, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code HQD

view all

More clearances from Bausch + Lomb, Incorporated

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.